NM_001244008.2:c.4927G>A
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1
The NM_001244008.2(KIF1A):c.4927G>A(p.Asp1643Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000459 in 1,611,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1643E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001244008.2 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 9Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- syndromic intellectual disabilityInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neuropathy, hereditary sensory, type 2CInheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- hereditary spastic paraplegia 30Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- PEHO syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary sensory and autonomic neuropathy type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001244008.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KIF1A | NM_001244008.2 | MANE Select | c.4927G>A | p.Asp1643Asn | missense | Exon 46 of 49 | NP_001230937.1 | ||
| KIF1A | NM_001379631.1 | c.5002G>A | p.Asp1668Asn | missense | Exon 46 of 49 | NP_001366560.1 | |||
| KIF1A | NM_001379642.1 | c.4927G>A | p.Asp1643Asn | missense | Exon 46 of 49 | NP_001366571.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KIF1A | ENST00000498729.9 | TSL:5 MANE Select | c.4927G>A | p.Asp1643Asn | missense | Exon 46 of 49 | ENSP00000438388.1 | ||
| KIF1A | ENST00000460788.5 | TSL:1 | n.1484G>A | non_coding_transcript_exon | Exon 6 of 9 | ||||
| KIF1A | ENST00000492812.6 | TSL:1 | n.3510G>A | non_coding_transcript_exon | Exon 13 of 16 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152196Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000362 AC: 89AN: 245806 AF XY: 0.000388 show subpopulations
GnomAD4 exome AF: 0.000473 AC: 691AN: 1459584Hom.: 0 Cov.: 30 AF XY: 0.000479 AC XY: 348AN XY: 726072 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000322 AC: 49AN: 152314Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4Benign:1
This variant is associated with the following publications: (PMID: 30564185)
KIF1A: PM2
not specified Uncertain:1Benign:1
Variant summary: KIF1A c.4624G>A (p.Asp1542Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00036 in 245806 control chromosomes (gnomAD). c.4624G>A has been reported in the literature in an individual affected with Hereditary Spastic Paraplegia without strong evidence of causality (D'Amore_2018). This report does not provide unequivocal conclusions about association of the variant with Hereditary Spastic Paraplegia 30. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication haz been ascertained in the context of this evaluation (PMID: 30564185). ClinVar contains an entry for this variant (Variation ID: 211292). Based on the evidence outlined above, the variant was classified as likely benign.
Intellectual disability, autosomal dominant 9 Uncertain:1
Neuropathy, hereditary sensory and autonomic, type 2A;C3280168:Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Uncertain:1
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at